Local Institution - 1810

Beijing, Beijing Municipality 100088

2 studies enrolling now · 2 studies all time

What they study most

Agitation, Alzheimer Disease

Studies at this site

• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) — Recruiting now
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) — Recruiting now